BeOne MedicinesONC -1.73%81 Days Inventory is 351.93 as of Mar. 2026, which is 16% above its 10-year median of 304.38. GuruFocus rates ONC with a GF Score™ of 81/100 and a GF Value™ of $366.06 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 638 Biotechnology companies, BeOne Medicines ranks worse than 68.65% on this metric.
The historical rank and industry rank for BeOne Medicines's Days Inventory or its related term are showing as below:
ONC'
s Days Inventory Range Over the Past 10 Years
Min: 114.83 Med: 304.38 Max: 802.06
Current: 306.8
During the past 13 years, BeOne Medicines's highest Days Inventory was 802.06. The lowest was 114.83. And the median was 304.38.
ONC's Days Inventory is ranked worse than 68.65% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs ONC: 306.80
BeOne Medicines's Days Inventory
increased
from Mar. 2025 (273.65) to Mar. 2026 (351.93).
It might indicate that BeOne Medicines's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
BeOne Medicines's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.26.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BeOne Medicines's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.43.
BeOne Medicines (NAS:ONC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
BeOne Medicines's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BeOne Medicines's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
BeOne Medicines Days Inventory Related Terms
BeOne Medicines Days Inventory Historical Data
* Premium members only.
The historical data trend for BeOne Medicines's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ONC vs MRNA, RPRX, ROIV: Days Inventory Comparison
For the Biotechnology subindustry, BeOne Medicines's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BeOne Medicines Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BeOne Medicines's Days Inventory distribution charts can be found below:
* The bar in red indicates where BeOne Medicines's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BeOne Medicines (ONC) has a Days Inventory of 351.93 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BeOne Medicines and its competitors. This is 16% above median its historical median of 304.38. Over the past decade, BeOne Medicines' Days Inventory has ranged from 114.83 to 802.06. According to the industry distribution chart, BeOne Medicines ranks #438 out of 638 companies in the Biotechnology industry, placing it in the top 68.7%.
Is BeOne Medicines' Days Inventory too high?
BeOne Medicines' current Days Inventory of 351.93 is 16% above median its 10-year median of 304.38. Over the past 10 years, this metric has ranged from a low of 114.83 to a high of 802.06. The Biotechnology industry median Days Inventory is 183.88. BeOne Medicines' value of 351.93 is 91.4% above this industry median. Based on the distribution chart, BeOne Medicines ranks #438 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, BeOne Medicines has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BeOne Medicines' Days Inventory compare to MRNA and RPRX?
According to the Biotechnology industry distribution chart, BeOne Medicines ranks #438 out of 638 companies for Days Inventory. This places BeOne Medicines in the lower half of its industry. The industry median Days Inventory is 183.88. BeOne Medicines' value of 351.93 is 91.4% above this benchmark. Historically, BeOne Medicines' own Days Inventory has ranged from 114.83 to 802.06 over the past decade. While the company's 10-year median is 304.38 vs. the industry median of 183.88, BeOne Medicines has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BeOne Medicines's current Days Inventory of 351.93 is 91.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BeOne Medicines and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BeOne Medicines's current Days Inventory is 351.93, which is 16% above median its own 10-year median of 304.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BeOne Medicines stock overvalued right now?
Based on GuruFocus' analysis, BeOne Medicines (ONC) is currently considered Modestly Undervalued. The stock's GF Value™ is $366.06, compared to a current price of $284.97 — trading 22.2% below its estimated fair value. The current Days Inventory is 351.93, which is 16% above median its 10-year median of 304.38 and 91.4% above the Biotechnology industry median of 183.88. BeOne Medicines' overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For BeOne Medicines (ONC), the current Days Inventory is 351.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BeOne Medicines (ONC) Overvalued in 2026?
Based on GuruFocus' analysis, BeOne Medicines stock appears to be undervalued.
The current stock price of $284.97 is trading 22.2% below its estimated GF Value™ of $366.06.
GuruFocus considers BeOne Medicines to be Modestly Undervalued.
Key valuation signals for ONC:
Days Inventory: 351.93 (16% above median its 10-year median of 304.38)
GF Value™: $366.06 vs. price of $284.97 (22.2% below fair value)
Industry Position: 91.4% above the Biotechnology median (#438 of 638)
No single metric tells the full story. See the ONC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of Non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up for 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has a global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes with AbbVie and AstraZeneca mainly. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.
81GF Score
Get the complete analysis for ONC
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ONC has been successfully added to your 
